Back
  1. Home
  2. Profile of Caroline Defraiteur (ULiège)
Profil

Defraiteur Caroline

See author's contact details
Main Referenced Co-authors
Luxen, André  (2)
Plenevaux, Alain  (2)
Aerts, Joël  (1)
Chappuis-Hugon, Florence (1)
Chiap, Patrice  (1)
Main Referenced Keywords
5-HT1A antagonists (1); 5-HT1A receptors (1); brain slices (1); dorsal raphe (1); MIP (1);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (2)
Chemistry (1)

Publications (total 2)

The most downloaded
216 downloads
Lecomte, F.* , Aerts, J.* , Plenevaux, A., Defraiteur, C., Chappuis-Hugon, F., Rozet, E., CHIAP, P., Luxen, A., Pichon, V., Hubert, P.* , & Hubert, C.*. (20 February 2020). Performance evaluation of a MIP for the MISPE-LC determination of p-[18F]MPPF and a potential metabolite in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 180. doi:10.1016/j.jpba.2019.113015 https://hdl.handle.net/2268/244275

The most cited

7 citations (Scopus®)

Defraiteur, C., Plenevaux, A., Scuvée-Moreau, J., Rouchet, N., Goblet, D., Luxen, A., & Seutin, V. (November 2007). Characterization of 4-(2-hydroxyphenyl)-1-[2 '-[N-(2 ''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. British Journal of Pharmacology, 152 (6), 952-958. doi:10.1038/sj.bjp.0707431 https://hdl.handle.net/2268/5146

Lecomte, F.* , Aerts, J.* , Plenevaux, A., Defraiteur, C., Chappuis-Hugon, F., Rozet, E., CHIAP, P., Luxen, A., Pichon, V., Hubert, P.* , & Hubert, C.*. (20 February 2020). Performance evaluation of a MIP for the MISPE-LC determination of p-[18F]MPPF and a potential metabolite in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 180. doi:10.1016/j.jpba.2019.113015
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Defraiteur, C., Plenevaux, A., Scuvée-Moreau, J., Rouchet, N., Goblet, D., Luxen, A., & Seutin, V. (November 2007). Characterization of 4-(2-hydroxyphenyl)-1-[2 '-[N-(2 ''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. British Journal of Pharmacology, 152 (6), 952-958. doi:10.1038/sj.bjp.0707431
Peer Reviewed verified by ORBi

Contact ORBi